Ability
Montreal, CA · 3 known investors
Ability is a biotechnology company developing highly-selective, immune cell-modulating antibody therapeutics for patients with inflammatory diseases and cancer. Its AbiLeap discovery engine uses AI and a database of antibody sequences to generate fully-human monospecific and bispecific antibodies, with a lead program targeting inflammatory skin diseases and other candidates for solid tumors.
Founders & leadership
GD
Giles DayinCo-founder
Investors · 3
In the news
Frequently asked questions
- What does Ability do?
- Ability is a biotechnology company developing highly-selective, immune cell-modulating antibody therapeutics for patients with inflammatory diseases and cancer. Its AbiLeap discovery engine uses AI and a database of antibody sequences to generate fully-human monospecific and bispecific antibodies, with a lead program targeting inflammatory skin diseases and other candidates for solid tumors.
- Who founded Ability?
- Ability was founded by Giles Day.
- Who are Ability's investors?
- Ability's investors include Page One Ventures, Alexandria, Fonds de solidarité FTQ.
- Where is Ability headquartered?
- Ability is headquartered in Montreal, CA.